SUPERNUS PHARMACEUTICALS, INC.·4

Mar 3, 4:09 PM ET

Mottola Frank 4

4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Mar 3, 2026

Insider Transaction Report

Form 4
Period: 2026-02-28
Mottola Frank
SVP, Chief Tech. Ops. Officer
Transactions
  • Award

    Performance Share Unit

    [F1]
    2026-02-28+3,7503,750 total
    Exercise: $0.00Common Stock (3,750 underlying)
Footnotes (1)
  • [F1]On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023.
Signature
/s/ Timothy C. Dec, as attorney-in-fact|2026-03-03

Documents

1 file
  • 4
    wk-form4_1772572184.xmlPrimary

    FORM 4